Asosiy kontentga oʻtish
Maqola

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

Matthew J. PageSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaDavid MoherCentre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, CanadaPatrick M. BossuytDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, NetherlandsIsabelle BoutronUniversité de Paris, Centre of Epidemiology and Statistics (CRESS), Inserm, F 75004 Paris, FranceTammy HoffmannInstitute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, AustraliaCynthia D. MulrowUniversity of Texas Health Science Center at San Antonio, San Antonio, Texas, United StatesLarissa ShamseerSchool of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, CanadaJennifer TetzlaffElie A. AklClinical Research Institute, American University of Beirut, Beirut, Lebanon; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, CanadaSue BrennanSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaRoger ChouDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, United StatesJulie GlanvilleUniversity of YorkJeremy GrimshawClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, CanadaAsbjørn HróbjartssonOpen Patient data Explorative Network, Odense University Hospital, Odense, DenmarkManoj M. LaluDepartment of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada; Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Canada; Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, CanadaTianjing LiDepartment of Ophthalmology, School of Medicine, University of Colorado Denver, Denver, Colorado, United StatesElizabeth LoderDivision of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States; Head of Research, The BMJ, London, UKEvan Mayo‐WilsonDepartment of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, United StatesSteve McDonaldSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaLuke A. McGuinnessPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKLesley StewartCentre for Reviews and Dissemination, University of York, York, UKJames ThomasEPPI-Centre, UCL Social Research Institute, University College London, London, UKAndrea C. TriccoLi Ka Shing Knowledge Institute of St. Michael's Hospital, Unity Health Toronto, Toronto, CanadaVivian WelchMethods Centre, Bruyère Research Institute, Ottawa, Ontario, CanadaPenny WhitingPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKJoanne E. McKenzieSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
2021en
ABI

Annotatsiya

The PRISMA 2020 statement includes a checklist of 27 items to guide reporting of systematic reviews In this article we explain why reporting of each item is recommended, present bullet points that detail the reporting recommendations, and present examples from published reviews We hope that uptake of the PRISMA 2020 statement will lead to more transparent, complete, and accurate reporting of systematic reviews, thus facilitating evidence based decision making on 1 September

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

10 ta iqtibos0 ta foydalanilgan manba